New Therapeutic Developments for Relapsed/Refractory Multiple Myeloma

In this online program experts discuss how to best use new therapeutic agents for patients with relapsed/refractory multiple myeloma. Watch the on-demand Webcast and download the slides from a dynamic online live CCO symposium plus access expert commentaries and a podcast on the new data to learn more about how to select optimal regimens for your patients with advanced myeloma.

This educational program is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline